Advertisement

Journal of Assisted Reproduction and Genetics

, Volume 32, Issue 8, pp 1221–1231 | Cite as

In vitro maturation (IVM) of oocytes recovered from ovariectomy specimens in the laboratory: a promising “ex vivo” method of oocyte cryopreservation resulting in the first report of an ongoing pregnancy in Europe

  • Ingrid SegersEmail author
  • Ileana Mateizel
  • Ellen Van Moer
  • Johan Smitz
  • Herman Tournaye
  • Greta Verheyen
  • Michel De Vos
Fertility Preservation

Abstract

Purpose

We present our center’s experience with 34 consecutive cases who underwent in vitro maturation (IVM) of oocytes obtained from ovariectomy specimens and compare our data with updated literature data.

Methods

Feasibility and efficiency of oocyte collection during ovarian tissue processing was assessed by the recovery rate, maturation rate, and embryological development after IVM.

Results

On average, 14 immature oocytes were retrieved per patient during ovarian tissue processing in 33/34 patients. The overall maturation rate after IVM was 36 %. The maturation rate correlated with the age of the patient and the duration of IVM. Predominately, oocyte vitrification was performed. Eight couples preferred embryo cryopreservation. Here, a 65 % fertilization rate was obtained and at least one good-quality day 3 embryo was cryopreserved in 7/8 couples. The retrieval of oocytes ex vivo resulted in mature oocytes or embryos available for vitrification in 79 % of patients. One patient with ovarian insufficiency following therapeutic embolization of the left uterine and the right ovarian artery because of an arteriovenous malformation had an embryo transfer of one good-quality warmed embryo generated after IVM ex vivo, which resulted in an ongoing clinical pregnancy.

Conclusions

IVM of oocytes obtained ex vivo during the processing of ovarian cortex prior to cryopreservation is a procedure with emerging promise for patients at risk for fertility loss, as illustrated by the reported pregnancy. However, more data are needed in order to estimate the overall success rate and safety of this novel approach.

Keywords

Fertility preservation In vitro maturation Ovarian cortex cryopreservation Oocyte Embryo 

Notes

Acknowledgments

The authors would like to thank the oncofertility team of the UZ Brussels and also give special thanks to the colleagues of the IVF laboratory, nurses, and doctors at the CRG and operating theater of UZ Brussels.

References

  1. 1.
    De Vos M, Smitz J, Woodruff TK. Fertility preservation in women with cancer. Lancet. 2014;384:1302–10.CrossRefPubMedGoogle Scholar
  2. 2.
    Ovarian tissue cryopreservation: a committee opinion. Fertil Steril. 2014;101:1237–43.CrossRefGoogle Scholar
  3. 3.
    Donnez J, Dolmans MM, Pellicer A, Diaz-Garcia C, Ernst E, Macklon KT, et al. Fertility preservation for age-related fertility decline. Lancet. 2015;385:506–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Revel A, Koler M, Simon A, Lewin A, Laufer N, Safran A. Oocyte collection during cryopreservation of the ovarian cortex. Fertil Steril. 2003;79:1237–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Revel A, Revel-Vilk S, Aizenman E, Porat-Katz A, Safran A, Ben-Meir A, et al. At what age can human oocytes be obtained? Fertil Steril. 2009;92:458–63.CrossRefPubMedGoogle Scholar
  6. 6.
    Isachenko E, Rahimi G, Isachenko V, Nawroth F. In-vitro maturation of germinal-vesicle oocytes and cryopreservation in metaphase I/II: a possible additional option to preserve fertility during ovarian tissue cryopreservation. Reprod Biomed Online. 2004;8:553–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Huang JY, Buckett WM, Gilbert L, Tan SL, Chian RC. Retrieval of immature oocytes followed by in vitro maturation and vitrification: a case report on a new strategy of fertility preservation in women with borderline ovarian malignancy. Gynecol Oncol. 2007;105:542–4.CrossRefPubMedGoogle Scholar
  8. 8.
    Huang JY, Tulandi T, Holzer H, Lau NM, Macdonald S, Tan SL, et al. Cryopreservation of ovarian tissue and in vitro matured oocytes in a female with mosaic Turner syndrome: Case Report. Hum Reprod. 2008;23:336–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Huang JY, Tulandi T, Holzer H, Tan SL, Chian RC. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril. 2008;89:567–72.CrossRefPubMedGoogle Scholar
  10. 10.
    Gonzalez C, Devesa M, Boada M, Coroleu B, Veiga A, Barri PN. Combined strategy for fertility preservation in an oncologic patient: vitrification of in vitro matured oocytes and ovarian tissue freezing. J Assist Reprod Genet. 2011;28:1147–9.PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Fasano G, Moffa F, Dechene J, Englert Y, Demeestere I. Vitrification of in vitro matured oocytes collected from antral follicles at the time of ovarian tissue cryopreservation. Reprod Biol Endocrinol. 2011;9:150.PubMedCentralCrossRefPubMedGoogle Scholar
  12. 12.
    Escriba MJ, Grau N, Escrich L, Novella-Maestre E, Sanchez-Serrano M. Spontaneous in vitro maturation of oocytes prior to ovarian tissue cryopreservation in natural cycles of oncologic patients. J Assist Reprod Genet. 2012;29:1261–5.PubMedCentralCrossRefPubMedGoogle Scholar
  13. 13.
    Imesch P, Scheiner D, Xie M, Fink D, Macas E, Dubey R, et al. Developmental potential of human oocytes matured in vitro followed by vitrification and activation. J Ovarian Res. 2013;6:30.PubMedCentralCrossRefPubMedGoogle Scholar
  14. 14.
    Wilken-Jensen HN, Kristensen SG, Jeppesen JV, Yding AC. Developmental competence of oocytes isolated from surplus medulla tissue in connection with cryopreservation of ovarian tissue for fertility preservation. Acta Obstet Gynecol Scand. 2014;93:32–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Prasath EB, Chan ML, Wong WH, Lim CJ, Tharmalingam MD, Hendricks M, et al. First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient. Hum Reprod. 2014;29:276–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Takae S, Sugishita Y, Yoshioka N, Hoshina M, Horage Y, Sato Y, et al. The role of menstrual cycle phase and AMH levels in breast cancer patients whose ovarian tissue was cryopreserved for oncofertility treatment. J Assist Reprod Genet. 2015;32:305–12.PubMedCentralCrossRefPubMedGoogle Scholar
  17. 17.
    Shirasawa H, Kumagai J, Sato W, Kumazawa Y, Sato N, Terada Y. Retrieval and in vitro maturation of human oocytes from ovaries removed during surgery for endometrial carcinoma: a novel strategy for human oocyte research. J Assist Reprod Genet. 2013;30:1227–30.PubMedCentralCrossRefPubMedGoogle Scholar
  18. 18.
    Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364:1405–10.CrossRefPubMedGoogle Scholar
  19. 19.
    Imbert R, Moffa F, Tsepelidis S, Simon P, Delbaere A, Devreker F, et al. Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis. Hum Reprod. 2014;29:1931–40.CrossRefPubMedGoogle Scholar
  20. 20.
    Rosendahl M, Greve T, Andersen CY. The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature. J Assist Reprod Genet. 2013;30:11–24.PubMedCentralCrossRefPubMedGoogle Scholar
  21. 21.
    Bastings L, Beerendonk CC, Westphal JR, Massuger LF, Kaal SE, van Leeuwen FE, et al. Autotransplantation of cryopreserved ovarian tissue in cancer survivors and the risk of reintroducing malignancy: a systematic review. Hum Reprod Update. 2013;19:483–506.CrossRefPubMedGoogle Scholar
  22. 22.
    Soares M, Saussoy P, Sahrari K, Amorim CA, Donnez J, Dolmans MM. Is transplantation of a few leukemic cells inside an artificial ovary able to induce leukemia in an experimental model? J Assist Reprod Genet. 2015;32:597–606.CrossRefPubMedGoogle Scholar
  23. 23.
    Luyckx V, Dolmans MM, Vanacker J, Legat C, Fortuno Moya C, Donnez J, et al. A new step toward the artificial ovary: survival and proliferation of isolated murine follicles after autologous transplantation in a fibrin scaffold. Fertil Steril. 2014;101:1149–56.CrossRefPubMedGoogle Scholar
  24. 24.
    Telfer EE, Zelinski MB. Ovarian follicle culture: advances and challenges for human and nonhuman primates. Fertil Steril. 2013;99:1523–33.PubMedCentralCrossRefPubMedGoogle Scholar
  25. 25.
    Meirow D, Levron J, Eldar-Geva T, Hardan I, Fridman E, Yemini Z, et al. Monitoring the ovaries after autotransplantation of cryopreserved ovarian tissue: endocrine studies, in vitro fertilization cycles, and live birth. Fertil Steril. 2007;87(418):e7–e15.PubMedGoogle Scholar
  26. 26.
    Dolmans MM, Donnez J, Camboni A, Demylle D, Amorim C, Van Langendonckt A, et al. IVF outcome in patients with orthotopically transplanted ovarian tissue. Hum Reprod. 2009;24:2778–87.CrossRefPubMedGoogle Scholar
  27. 27.
    Anderson RA, McLaughlin M, Wallace WH, Albertini DF, Telfer EE. The immature human ovary shows loss of abnormal follicles and increasing follicle developmental competence through childhood and adolescence. Hum Reprod. 2014;29:97–106.PubMedCentralCrossRefPubMedGoogle Scholar
  28. 28.
    Hambridge HL, Mumford SL, Mattison DR, Ye A, Pollack AZ, Bloom MS, et al. The influence of sporadic anovulation on hormone levels in ovulatory cycles. Hum Reprod. 2013;28:1687–94.PubMedCentralCrossRefPubMedGoogle Scholar
  29. 29.
    Sonigo C, Grynberg M. In vitro oocyte maturation for female fertility preservation. Gynecol Obstet Fertil. 2014;42:657–60.CrossRefPubMedGoogle Scholar
  30. 30.
    Son WY, Chung JT, Herrero B, Dean N, Demirtas E, Holzer H, et al. Selection of the optimal day for oocyte retrieval based on the diameter of the dominant follicle in hCG-primed in vitro maturation cycles. Hum Reprod. 2008;23:2680–5.CrossRefPubMedGoogle Scholar
  31. 31.
    Guzman L, Adriaenssens T, Ortega-Hrepich C, Albuz FK, Mateizel I, Devroey P, et al. Human antral follicles <6 mm: a comparison between in vivo maturation and in vitro maturation in non-hCG primed cycles using cumulus cell gene expression. Mol Hum Reprod. 2013;19:7–16.CrossRefPubMedGoogle Scholar
  32. 32.
    De Munck N, Petrussa L, Verheyen G, Staessen C, Vandeskelde Y, Sterckx J et al. Chromosomal meiotic segregation, embryonic developmental kinetics and DNA (hydroxy)methylation analysis consolidate the safety of human oocyte vitrification. Mol Hum Reprod. 2015.Google Scholar
  33. 33.
    Stoop D, De Munck N, Jansen E, Platteau P, Van den Abbeel E, Verheyen G, et al. Clinical validation of a closed vitrification system in an oocyte-donation programme. Reprod Biomed Online. 2012;24:180–5.CrossRefPubMedGoogle Scholar
  34. 34.
    Wang H, Racowsky C, Combelles CM. Is it best to cryopreserve human cumulus-free immature oocytes before or after in vitro maturation? Cryobiology. 2012;65:79–87.CrossRefPubMedGoogle Scholar
  35. 35.
    Fasano G, Demeestere I, Englert Y. In-vitro maturation of human oocytes: before or after vitrification? J Assist Reprod Genet. 2012;29:507–12.PubMedCentralCrossRefPubMedGoogle Scholar
  36. 36.
    Brambillasca F, Guglielmo MC, Coticchio G, Mignini Renzini M, Dal Canto M, Fadini R. The current challenges to efficient immature oocyte cryopreservation. J Assist Reprod Genet. 2013;30:1531–9.PubMedCentralCrossRefPubMedGoogle Scholar
  37. 37.
    Chian RC, Huang JY, Gilbert L, Son WY, Holzer H, Cui SJ, et al. Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes. Fertil Steril. 2009;91:2391–8.CrossRefPubMedGoogle Scholar
  38. 38.
    Chian RC, Gilbert L, Huang JY, Demirtas E, Holzer H, Benjamin A, et al. Live birth after vitrification of in vitro matured human oocytes. Fertil Steril. 2009;91:372–6.CrossRefPubMedGoogle Scholar
  39. 39.
    El Hachem H, Poulain M, Finet A, Fanchin R, Frydman N, Grynberg MH. Live birth after frozen-thawed oocytes matured in vitro in a PCOS patient: a model for improving implantation rates in IVM cycles and objectively assessing the real potential of development of frozen oocytes matured in vitro. Gynecol Endocrinol. 2014;30:415–8.CrossRefPubMedGoogle Scholar
  40. 40.
    Fadini R, Dal Canto M, Mignini Renzini M, Milani R, Fruscio R, Cantu MG, et al. Embryo transfer following in vitro maturation and cryopreservation of oocytes recovered from antral follicles during conservative surgery for ovarian cancer. J Assist Reprod Genet. 2012;29:779–81.PubMedCentralCrossRefPubMedGoogle Scholar
  41. 41.
    Vanhoutte L, Cortvrindt R, Nogueira D, Smitz J. Effects of chilling on structural aspects of early preantral mouse follicles. Biol Reprod. 2004;70:1041–8.CrossRefPubMedGoogle Scholar
  42. 42.
    Combelles CM, Chateau G. The use of immature oocytes in the fertility preservation of cancer patients: current promises and challenges. Int J Dev Biol. 2012;56:919–29.CrossRefPubMedGoogle Scholar
  43. 43.
    Chian RC, Wang Y, Li YR. Oocyte vitrification: advances, progress and future goals. J Assist Reprod Genet. 2014;31:411–20.PubMedCentralCrossRefPubMedGoogle Scholar
  44. 44.
    Quintans CJ, Donaldson MJ, Urquiza MF, Carretero I, Pasqualini RA, Horton M, et al. Live birth of twins after IVF of oocytes that were cryopreserved almost 12 years before. Reprod Biomed Online. 2012;25:600–2.CrossRefPubMedGoogle Scholar
  45. 45.
    Huang JY, Chian RC, Gilbert L, Fleiszer D, Holzer H, Dermitas E, et al. Retrieval of immature oocytes from unstimulated ovaries followed by in vitro maturation and vitrification: A novel strategy of fertility preservation for breast cancer patients. Am J Surg. 2010;200:177–83.CrossRefPubMedGoogle Scholar
  46. 46.
    Dittrich R, Lotz L, Mueller A, Hoffmann I, Wachter DL, Amann KU, et al. Oncofertility: combination of ovarian stimulation with subsequent ovarian tissue extraction on the day of oocyte retrieval. Reprod Biol Endocrinol. 2013;11:19.PubMedCentralCrossRefPubMedGoogle Scholar
  47. 47.
    Dolmans MM, Marotta ML, Pirard C, Donnez J, Donnez O. Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes. J Ovarian Res. 2014;7:80.PubMedCentralCrossRefPubMedGoogle Scholar
  48. 48.
    Soderstrom-Anttila V, Salokorpi T, Pihlaja M, Serenius-Sirve S, Suikkari AM. Obstetric and perinatal outcome and preliminary results of development of children born after in vitro maturation of oocytes. Hum Reprod. 2006;21:1508–13.CrossRefPubMedGoogle Scholar
  49. 49.
    Basatemur E, Sutcliffe A. Health of IVM children. J Assist Reprod Genet. 2011;28:489–93.PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Ingrid Segers
    • 1
    Email author
  • Ileana Mateizel
    • 1
  • Ellen Van Moer
    • 1
  • Johan Smitz
    • 2
  • Herman Tournaye
    • 1
  • Greta Verheyen
    • 1
  • Michel De Vos
    • 1
  1. 1.Centre for Reproductive MedicineUZ BrusselBrusselsBelgium
  2. 2.Laboratory of Clinical Chemistry and Radioimmunology, Follicle Biology Unit (FOBI)UZ Brussel, Vrije Universiteit BrusselBrusselsBelgium

Personalised recommendations